The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Inhalation drug delivery devices: technology update
Open accessAbstract
The pulmonary route of administration has proven to be effective in local and systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non-pulmonary diseases. A successful pulmonary administration requires a harmonic interaction between the drug formulation, the inhaler device, and the patient. However, the biggest single problem that accounts for the lack of desired effect or adverse outcomes is the incorrect use of the device due to lack of training in how to use the device or how to coordinate actuation and aerosol inhalation. This review summarizes the structural and mechanical features of aerosol delivery devices with respect to mechanisms of aerosol generation, their use with different formulations, and their advantages and limitations. A technological update of the current state-of-the-art designs proposed to overcome current challenges of existing devices is also provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01892.x · Cited by 1,245
What the pulmonary specialist should know about the new inhalation therapies
Laube, B. L., Janssens, H. M., de Jongh, F. H. C., Devadason, S. G., Dhand, R., Diot, P., Everard, M. L., Horvath, I., Navalesi, P., Voshaar, T., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00166410 · Cited by 806
Particle Engineering for Pulmonary Drug Delivery
Chow, A. H. L., Tong, H. H. Y., Chattopadhyay, P., & Shekunov, B. Y. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9174-3 · Cited by 645
Deposition, retention, and clearance of inhaled particles.
Lippmann, M., Yeates, D. B., & Albert, R. E. (1980) · Occupational and Environmental Medicine · doi:10.1136/oem.37.4.337 · Cited by 557
Aerosol drug delivery: developments in device design and clinical use
Dolovich, M. B., & Dhand, R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60926-9 · Cited by 505
Aerosol Deposition in Health and Disease
Darquenne, C. (2012) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2011.0916 · Cited by 452
Labiris, N. R., & Dolovich, M. B. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01893.x · Cited by 451
A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
Hodson, M. E., Gallagher, C. G., & Govan, J. R. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00248102 · Cited by 269
Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices
LENNEY, J., INNES, J. A., & CROMPTON, G. K. (2000) · Respiratory Medicine · doi:10.1053/rmed.1999.0767 · Cited by 266
Aerosol deposition considerations in inhalation therapy
Newman, S. P. (1985) · Chest · doi:10.1378/chest.88.2.152s · Cited by 264
Principles of Metered-Dose Inhaler Design
Newman, S. P. (2005) · Respiratory Care · doi:10.4187/respcare.05501177 · Cited by 244
Dry Powder Aerosols I: A New Powder Inhalation Device
Bell, J. H., Hartley, P. S., & Cox, J. S. G. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600601028 · Cited by 202
Inhalation therapy: an historical review
Sanders, M. (2007) · Primary Care Respiratory Journal · doi:10.3132/pcrj.2007.00017 · Cited by 199
Dispersion and Characterization of Pharmaceutical Dry Powder Aerosols
Dunber, C. A., Hickey, A. J., & Holzner, P. (1998) · KONA Powder and Particle Journal · doi:10.14356/kona.1998007 · Cited by 197
Emerging inhalation aerosol devices and strategies: Where are we headed?
Zhou, Q. (., Tang, P., Leung, S. S. Y., Chan, J. G. Y., & Chan, H.-K. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.006 · Cited by 188
Islam, N., & Cleary, M. J. (2012) · Medical Engineering & Physics · doi:10.1016/j.medengphy.2011.12.025 · Cited by 187
Nebulizers: Principles and Performance
HESS, D. R. (2000) · Respiratory Care · doi:10.1177/002013240004500605 · Cited by 166
Smyth, H. D. C. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00079-6 · Cited by 159
Inhaler devices – From theory to practice
Sanchis, J., Corrigan, C. J., Levy, M. L., & Viejo, J. L. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2012.12.007 · Cited by 155
The Challenge of Delivering Therapeutic Aerosols to Asthma Patients
Lavorini, F. (2013) · ISRN Allergy · doi:10.1155/2013/102418 · Cited by 133
Latest advances in the development of dry powder inhalers
Ashurst, I., Malton, A., Prime, D., & SUMBY, B. S. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00275-3 · Cited by 128
History of Aerosol Therapy: Liquid Nebulization to MDIs to DPIs
ANDERSON, P. J. (2005) · Respiratory Care · doi:10.4187/respcare.05501139 · Cited by 120
Aerosol Delivery Device Selection for Spontaneously Breathing Patients: 2012
Ari, A., & Restrepo, R. D. (2012) · Respiratory Care · doi:10.4187/respcare.01756 · Cited by 89
Svedsäter, H., Dale, P., Garrill, K., Walker, R. W., & Woepse, M. W. (2013) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-13-72 · Cited by 77
Fischer, A., Stegemann, J., Scheuch, G., & Siekmeier, R. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-s4-71 · Cited by 64
Mechanisms of Absorption and Elimination of Drugs Administered By Inhalation
Ibrahim, M., & Garcia‐Contreras, L. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.67 · Cited by 63
Self-citationParticle transport onto human airway surfaces.
Heyder, J. (1982) · PubMed · Cited by 58
Emerging aerosol drug delivery strategies: From bench to clinic
Rubin, B. K., & Williams, R. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.008 · Cited by 58
Aerosol Delivery of DNA/Liposomes to the Lung for Cystic Fibrosis Gene Therapy
Davies, L. A., Nunez-Alonso, G. A., McLachlan, G., Hyde, S. C., & Gill, D. R. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/hum.2014.019 · Cited by 56
Geller, D. E., & Kesser, K. C. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0793 · Cited by 49
Lung Anatomy and Physiology and Their Implications for Pulmonary Drug Delivery
Verma, R. K., Ibrahim, M., & Garcia‐Contreras, L. (2015) · Wiley eBooks · doi:10.1002/9781118799536.ch1 · Cited by 45
Self-citationPropellant-driven metered-dose inhalers for pulmonary drug delivery
Smyth, H. D. C. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.53 · Cited by 39
Zanen, P., Go, L. T., & Lammers, J. J. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050415 · Cited by 29
Manufacturing and Device Options for the Delivery of Biotherapeutics
Hoe, S., Boraey, M. A., Ivey, J. W., Finlay, W. H., & Vehring, R. (2013) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2013.1090 · Cited by 24
In Vitro Reporter Gene Transfection via Plasmid DNA Delivered by Metered Dose Inhaler
Bains, B. K., Birchall, J. C., Toon, R. C., & Taylor, G. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22085 · Cited by 21
Simis, K., Lei, M., Lu, A. T., Sharma, K. C. V., Hale, R. L., Timmons, R., & Cassella, J. V. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802149061 · Cited by 11
Cited by
Inhaled Therapy in Respiratory Disease: The Complex Interplay of Pulmonary Kinetic Processes
Borghardt, J. M., Kloft, C., & Sharma, A. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/2732017 · Cited by 304
Metadata
- Authors
- Garcia-Contreras, L., Ibrahim, M., & Verma, R.
- Venue
- Medical Devices: Evidence and Research
- Publisher
- Informa UK Limited
- Published
- 2015-02
- Volume
- 8
- Pages
- 131
- ISSN
- 1179-1470 (ISSN-L)
- OpenAlex
- W2018698029
- Cited by
- 306
- References
- 37
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.